Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03322540
Title Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST